v1
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation.
Identifier:nobleid.org/w1/20260515/DD1D2CF7
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/DD1D2CF7)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims